Cannara Biotech (OTCMKTS:CNBTF) Shares Up 3.5% – Still a Buy?

Shares of Cannara Biotech (OTCMKTS:CNBTF) shot up 3.5% during trading on Tuesday . The stock traded as high as $1.2050 and last traded at $1.2001. 4,535 shares were traded during mid-day trading, a decline of 86% from the average session volume of 33,127 shares. The stock had previously closed at $1.16.

Cannara Biotech Stock Performance

The company’s 50-day moving average is $1.28 and its two-hundred day moving average is $1.29.

Cannara Biotech Holdings Inc (OTCMKTS:CNBTF) is a biotechnology and natural health company focused on the development, production and distribution of plant-derived formulations, including cannabinoid-based products. Headquartered in Canada, the company integrates research and development with large-scale extraction and formulation processes to serve the pharmaceutical, cosmetic and wellness industries.

The company’s offerings comprise high-purity botanical extracts, nutraceutical ingredients and cosmetic actives developed using proprietary extraction and purification techniques.